Info@ThinkPinkRocks.com

Twist Bioscience raises $26M in Series B financing, receives $5.1M DARPA contract

Twist Bioscience today announced that it raised $26 million in a Series B financing to commercialize the company’s semiconductor-based synthetic gene manufacturing process.

Originally posted here:
Twist Bioscience raises $26M in Series B financing, receives $5.1M DARPA contract

Share

Leave a Reply